EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 123 filers reported holding EPIZYME INC in Q1 2019. The put-call ratio across all filers is 1.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,000 | -46.9% | 14,841 | +17.0% | 0.00% | 0.0% |
| Q4 2021 | $32,000 | -51.5% | 12,682 | -1.4% | 0.00% | -50.0% |
| Q3 2021 | $66,000 | +312.5% | 12,865 | +576.4% | 0.00% | +100.0% |
| Q2 2021 | $16,000 | -44.8% | 1,902 | -41.9% | 0.00% | 0.0% |
| Q1 2021 | $29,000 | -53.2% | 3,273 | -42.5% | 0.00% | -66.7% |
| Q4 2020 | $62,000 | +463.6% | 5,695 | +530.0% | 0.00% | +200.0% |
| Q3 2020 | $11,000 | -93.3% | 904 | -91.1% | 0.00% | -94.4% |
| Q2 2020 | $163,000 | +1937.5% | 10,179 | +1838.9% | 0.02% | +350.0% |
| Q1 2020 | $8,000 | +100.0% | 525 | +67.2% | 0.00% | +100.0% |
| Q1 2019 | $4,000 | – | 314 | +946.7% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 30 | -98.4% | 0.00% | -100.0% |
| Q1 2018 | $34,000 | +3300.0% | 1,899 | +4120.0% | 0.02% | +1700.0% |
| Q4 2017 | $1,000 | -75.0% | 45 | -79.0% | 0.00% | -66.7% |
| Q3 2017 | $4,000 | – | 214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |